| DBVTDBV Technologies S.A. | 5,213,361 | $108.9M |
| CGEMCullinan Therapeutics, Inc. | 7,648,268 | $108.7M |
| AKTSAktis Oncology Inc. | 4,835,872 | $86.5M |
| LQDALiquidia Corp | 1,405,158 | $53.0M |
| ALMSALUMIS INC. | 2,386,529 | $52.6M |
| EWTXEdgewise Therapeutics, Inc. | 1,660,696 | $52.3M |
| RVMDREVOLUTION MEDICINES, INC. | 506,776 | $49.3M |
| AGIOAGIOS PHARMACEUTICALS, INC. | 1,306,261 | $44.2M |
| CORTCORCEPT THERAPEUTICS INC | 985,700 | $39.7M |
| TRVITrevi Therapeutics, Inc. | 3,298,430 | $39.4M |
| DNTHDianthus Therapeutics, Inc. /DE/ | 423,982 | $35.6M |
| XENEXenon Pharmaceuticals Inc. | 588,706 | $34.2M |
| MLTXMoonLake Immunotherapeutics | 1,811,082 | $33.8M |
| TVTXTravere Therapeutics, Inc. | 1,133,365 | $33.7M |
| EVMNEvommune, Inc. | 1,455,863 | $33.5M |
| CYTKCYTOKINETICS INC | 500,000 | $33.0M |
| SNDXSyndax Pharmaceuticals Inc | 1,340,733 | $31.3M |
| CNTXContext Therapeutics Inc. | 10,679,391 | $28.0M |
| FBRXForte Biosciences, Inc. | 1,000,682 | $25.9M |
| PVLAPALVELLA THERAPEUTICS, INC. | 206,404 | $25.7M |
| DYNDyne Therapeutics, Inc. | 1,408,152 | $25.5M |
| STOKStoke Therapeutics, Inc. | 767,038 | $25.0M |
| CRVSCorvus Pharmaceuticals, Inc. | 1,674,875 | $24.5M |
| RLAYRelay Therapeutics, Inc. | 2,359,586 | $23.5M |
| TARSTarsus Pharmaceuticals, Inc. | 329,750 | $23.1M |
| ORICOric Pharmaceuticals, Inc. | 1,803,945 | $22.9M |
| QUREuniQure N.V. | 1,369,231 | $22.4M |
| GLUEMonte Rosa Therapeutics, Inc. | 1,176,928 | $19.4M |
| CLYMClimb Bio, Inc. | 2,593,439 | $17.8M |
| ARQTArcutis Biotherapeutics, Inc. | 733,966 | $17.3M |
| URGNUroGen Pharma Ltd. | 943,803 | $17.0M |
| DRUGBRIGHT MINDS BIOSCIENCES INC. | 212,175 | $15.5M |
| ZYMEZymeworks Inc. | 565,249 | $14.2M |
| BLTEBELITE BIO, INC | 88,045 | $14.0M |
| VRDNViridian Therapeutics, Inc.\DE | 649,873 | $12.7M |
| ABVXAbivax SA | 107,268 | $11.9M |
| ALLOAllogene Therapeutics, Inc. | 2,242,933 | $5.5M |
| ACRSAclaris Therapeutics, Inc. | 391,918 | $1.5M |
| HOWLWerewolf Therapeutics, Inc. | 1,208,810 | $1.0M |